Live feed
·
INSIDERFilingvia Quantisnow
Bolt Biotherapeutics Inc. logo

Bolt Biotherapeutics (BOLT) CEO Quinn bought 125 shares for $687 at $5.49

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

William P. Quinn (President, CEO and CFO at Bolt Biotherapeutics Inc., BOLT) reported that they bought 125 shares for $687 at $5.49, and received 40,000 shares between Jun 6, 2025 and Oct 22, 2025. After these transactions the filing shows 42,188 shares held directly.

Reporting person
Quinn William P.
Role
President, CEO and CFO
Common stock and other non-derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Jun 6, 2025Open-market purchase (P)Common Stock1+125$5.49$6872,188 direct
Oct 22, 2025Grant or award (A)Common Stock2, 3+40,000--42,188 direct

Holdings before and after

  • Common Stock: 2,063 to 42,188 direct

Footnotes from the filing

  1. 1. Shares acquired under the issuer's Employee Stock Purchase Plan and therefore exempt under Rule 16b-3(c)
  2. 2. The shares represent restricted stock units that were received as an award, for no consideration. Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
  3. 3. The restricted stock units subject to the award will vest in full on September 15, 2026, assuming continued employment through such date.

Transaction codes in this filing

Open-market purchase:
Code P marks a purchase in the open market or a private deal. The insider paid for these securities.
Grant or award:
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ

What did Quinn report in this BOLT Form 4?

William P. Quinn (President, CEO and CFO at Bolt Biotherapeutics Inc., BOLT) reported that they bought 125 shares for $687 at $5.49, and received 40,000 shares between Jun 6, 2025 and Oct 22, 2025. After these transactions the filing shows 42,188 shares held directly.

How many BOLT shares does Quinn hold after this filing?

The filing shows 42,188 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.

What does transaction code P mean on an SEC Form 4?

Code P marks a purchase in the open market or a private deal. The insider paid for these securities.

Historical context for BOLT

Earlier insider filings at BOLT

Quantisnow market dataNASDAQ
Bolt Biotherapeutics Inc. logo
BOLT
Bolt Biotherapeutics Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2021
Get push alerts for BOLT

Follow BOLT and get a push notification the moment its next story breaks.

Full BOLT profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BOLT (Bolt Biotherapeutics Inc.) and more on Quantisnow.